Jaguar Health Soars 32% as Rare-Disease Pipeline News Meets Thin Post-Split Float

Jaguar Health is surging on a float so thin that a handful of trades can swing the price wildly, while a rare pediatric disease program edges closer to a pivotal regulatory filing that could either validate the rally or expose how fragile it really is.